Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 31;64(4):2401222.
doi: 10.1183/13993003.01222-2024. Print 2024 Oct.

The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona

Marc Humbert  1 , Nazzareno Galiè  2   3 , Lewis J Rubin  4 , Gérald Simonneau  5 , Vallerie V McLaughlin  6
Affiliations
Editorial

The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona

Marc Humbert et al. Eur Respir J. .

Abstract

Since 1960, pulmonary hypertension has been the focus of WHO committee reports and World Symposia proceedings. The conclusions from the 7th World Symposium on Pulmonary Hypertension are now published in the European Respiratory Journal. https://bit.ly/4ePMZ6H

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. Humbert reports grants from Gossamer and Merck, consultancy fees from 35 Pharma, Aerovate, AOP Orphan, Chiesi, Ferrer, Gossamer, Janssen, Keros, Liquidia, Merck, Novartis, Respira, Roivant and United Therapeutics, payment or honoraria for lectures, presentations, manuscript writing or educational events from Janssen and Merck, and participation on a data safety monitoring board or advisory board with 35 Pharma, Aerovate, Janssen, Keros, Merck, Novartis and United Therapeutics. N. Galiè reports grants from Janssen, Actelion and Merck, consultancy fees and payment or honoraria for lectures, presentations, manuscript writing or educational events from Janssen, Actelion, Chiesi and Ferrer, support for attending meetings from Dompe, and participation on a data safety monitoring board or advisory board with Janssen, Actelion and Ferrer. L.J. Rubin reports consultancy fees from Gossamer and SoniVie, payment for expert testimony from Sandoz, and is a member of the Organizing and Founders Committees, WSPH. G. Simonneau has no potential conflicts of interest to disclose. V.V. McLaughlin reports grants from Aerovate, Gossamer-Bio, Janssen, Keros, Merck and Sonovie, and consultancy fees from 35Pharma, Aerami, Aerovate, Caremark, L.L.C., Corvista, Gossamer Bio, Janssen, Keros, Merck, Riovant and United Therapeutics.

Figures

FIGURE 1
FIGURE 1
Historical perspective of the World Health Organization (WHO) Committees and World Symposia on Pulmonary Hypertension (1960–2024).
See this image and copyright information in PMC

Comment on

References

    1. World Health Organization. Report of the WHO Expert Committee on Chronic Cor Pulmonale. WHO Technical Report Series, Number 213. Geneva, WHO, 1961. - PubMed
    1. Hatano S, Strasser T, eds. Primary Pulmonary Hypertension. Report on a WHO Meeting. Geneva, World Health Organization, 1975; pp. 7–45.
    1. Rich S, Dantzer DR, Ayres SM, et al. . Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216–228. doi:10.7326/0003-4819-107-2-216 - DOI - PubMed
    1. Rich S, ed. Executive Summary from the World Symposium – Primary Pulmonary Hypertension. www.wsphassociation.org/wp-content/uploads/2019/04/Primary-Pulmonary-Hyp...
    1. Galiè N, Rubin LJ. Introduction: new insights into a challenging disease; a review of the third World Symposium on Pulmonary Arterial Hypertension. J Am Coll Cardiol 2004; 43: 2S–4S. doi:10.1016/j.jacc.2004.03.019 - DOI - PubMed

LinkOut - more resources